1832 Asset Management’s BioTelemetry, Inc. BEAT Stock Holding History

1832 Asset Management’s Portfolio BEAT Stock Details BEAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-800	Closed	-$58K	–	808
2020 Q4	$58K	Hold	800	–	–	﹤0.01%	618
2020 Q3	$36K	Hold	800	–	–	﹤0.01%	605
2020 Q2	$36K	Hold	800	–	–	﹤0.01%	574
2020 Q1	$31K	Hold	800	–	–	﹤0.01%	601
2019 Q4	$37K	Hold	800	–	–	﹤0.01%	572
2019 Q3	$33K	Hold	800	–	–	﹤0.01%	587
2019 Q2	$39K	Hold	800	–	–	﹤0.01%	588
2019 Q1	$50K	Hold	800	–	–	﹤0.01%	511
2018 Q4	$48K	Hold	800	–	–	﹤0.01%	487
2018 Q3	$52K	Hold	800	–	–	﹤0.01%	543
2018 Q2	$40K	Hold	800	–	–	﹤0.01%	522
2018 Q1	$25K	Hold	800	–	–	﹤0.01%	566
2017 Q4	$24K	Hold	800	–	–	﹤0.01%	581
2017 Q3	$26K	Hold	800	–	–	﹤0.01%	594
2017 Q2	$27K	Hold	800	–	–	﹤0.01%	574
2017 Q1	$23K	Buy	+800	New	+$19.8K	﹤0.01%	628

Other funds holding BEAT

LCM

Logan Capital Management Newtown Square, Pennsylvania $2.3B AUM 30.85% 1-Year Est. Return

1832 Asset Management's BEAT Position: Q1 2021 in Review

1832 Asset Management sold out of BioTelemetry, Inc. (BEAT) in Q1 2021, closing a stake of 800 shares — an estimated $58K sold.

1832 Asset Management first reported a position in BEAT in Q1 2017 and held it in 16 quarters. The position peaked at $58K in Q4 2020. 1 fund tracked by Wall St. Rank holds BEAT as of Q1 2021.

1832 Asset Management reported no remaining BioTelemetry, Inc. position as of Q1 2021 after selling out during the quarter.
1832 Asset Management sold 800 BioTelemetry, Inc. shares in Q1 2021, an estimated $58K.
1832 Asset Management first reported a position in BioTelemetry, Inc. in Q1 2017 and held it in 16 quarters.
1832 Asset Management's BioTelemetry, Inc. position peaked at $58K in Q4 2020.
1 fund tracked by Wall St. Rank held BioTelemetry, Inc. as of Q1 2021.

Based on 1832 Asset Management's 13F filing for Q1 2021, filed 17 May 2021.